Eli Lilly’s stock falls after fake blue-check tweet

November 13, 2022

Eli Lilly’s stock fell millions in a single day to $14 billion, all thanks to a fake “verified” account on Elon Musk’s new Twitter payment system.

That account impersonated Eli Lilly and tweeted “insulin is free now,” implying that the pharmaceutical company’s insulin would soon be free.

Other Health care stocks such as Novo Nordisk and Sanofi also came under pressure on Friday, with Novo Nordisk shares falling 3.5% to 111.47 and Sanofi’s losing 3.4% to finish the regular session at 42.80, possibly in solidarity with Eli Lilly.

Although the account was quickly suspended, the damage had already been done, as worried shareholders confused it with reality and sold shares at a rapid pace.

Twitter’s disinformation problem is exacerbated by the democratization of the Blue Check, which has since been halted. Several corporate and government imposters targeted Eli Lilly and Company, including fake accounts for defense manufacturer Lockheed Martin, oil company BP, and produce distributor Chiquita.

The sources for this piece include an article in Investors.com.

Top Stories

Related Articles

March 9, 2026 Oracle is reportedly considering cutting between 20,000 and 30,000 jobs as it seeks to fund a large more...

March 9, 2026 A U.S. federal judge has denied Elon Musk’s xAI request for a preliminary injunction that would have more...

March 9, 2026 MDA Space says it is expanding satellite production and targeting more defence contracts as governments increase military more...

March 4, 2026 OpenAI is developing an internal code-hosting platform that could compete with Microsoft-owned GitHub, according to a report more...

Jim Love

Jim is an author and podcast host with over 40 years in technology.

Share:
Facebook
Twitter
LinkedIn